Search - tctmd.com

Displaying 461 - 480 of 571

Sort: Relevancy | Date

Presentation TCT 2013

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Presenter: Elvin Kedhi

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

Presenter: Si-Hyuck Kang

October 29, 2013

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

Presentation Scripps 2013

Drug-eluting Stents 2013: Current Data, Future Advances

Presenter: James B. Hermiller, Jr.

October 03, 2013

Presentation SOLACI 2013

Drug-Eluting Stent Is the Default Strategy for Acute Coronary Syndrome?

Presenter: Luiz A. Mattos

July 25, 2013

Presentation

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Presenter: L. Holmvang

June 24, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

Presentation Fellows 2013

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2013

Presentation ACC 2013

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 09, 2013

Presentation TCT 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati

January 31, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Presenter: Piero Montorsi, Antonio Bartorelli, Franco Fabbiocchi, Stefano Galli, Alessandro Lualdi, Paolo Ravagnani, Giovanni Teruzzi, Daniela Trabattoni, Sarah Troiano

January 31, 2013

Presentation TCT 2013

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

Presenter: Fazilatum Nesa Malik, Antonio Serra, Nick West, Werner Scholtz, Farzin FATH-ORDOUBADHI, Teguh Santoso, Peep Laanmets, Werner Jung, Fraser WITHEROW, Stefan HOFFMANN, Mohsen Mohandes, Gian Battista Danzi

January 31, 2013

Presentation TCT 2013

The longitudinal elongation of the contemporary drug eluting stent in a tapered bench-top model.

Presenter: Masaki Takenaka, Haruo Hirayama, Kenji Hurusawa, Mamoru Nanasato, Takamitu Nin, Yukihiko Yoshida, Ruka Yoshida, Hiroki Kamiya

January 31, 2013

Presentation TCT 2013

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Short and Long Term Clinical Outcomes of Left Main Treatment with a Latest Generation Drug Eluting Stent

Presenter: Bernard Chevalier, Christian Dina, Stefan HOFFMANN, Nikola Jagic, Yu Jiangtao, Ren? Koning, Ran Kornowski, Peep Laanmets, Zoran Perisic, Teguh Santoso

January 31, 2013

Presentation TCT 2013

Short and Long Term Clinical Outcomes of Chronic Total Occlusion Treatment with a Latest Generation Drug Eluting Stent

Presenter: Alejandro Alcocer Chauvet, Ralf Blank, Attila Dirkali, Sagar Doshi, Andrejs Erglis, Paul Hsien-Li Kao, Chaim Lotan, Aleksandar NESKOVIC, Jawed Polad, Sergei Vlasenko

January 31, 2013

Presentation TCT 2013

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Presenter: Samer Somi, Wouter Remkes, Jan-Henk Dambrink, Marcel Gosselink, Jan Hoorntje, Harry Suryapranata, Jan Paul Ottervanger, Arnoud van 't Hof

January 31, 2013

Presentation TCT 2013

Predictors of Stent Fracture and Impact on Neointimal Proliferation: Experimental Insights into the Mechanisms of Drug Eluting Stent Failure

Presenter: Seung-Jin Oh, Jong Shiuan Yeh, Piotr Buszman, Maxwell Afari, Armando Tellez, Yanping Cheng, Gerard Conditt, Jenn McGregor, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Drug-eluting Stents 2013: Current Data, Future Advances

Drug-Eluting Stent Is the Default Strategy for Acute Coronary Syndrome?

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Drug-Eluting Stents: Past, Present, and Future

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

The longitudinal elongation of the contemporary drug eluting stent in a tapered bench-top model.

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Short and Long Term Clinical Outcomes of Left Main Treatment with a Latest Generation Drug Eluting Stent

Short and Long Term Clinical Outcomes of Chronic Total Occlusion Treatment with a Latest Generation Drug Eluting Stent

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Predictors of Stent Fracture and Impact on Neointimal Proliferation: Experimental Insights into the Mechanisms of Drug Eluting Stent Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content